Frailty in People with HIV Is Linked to Inflammation, Bone Health, and T-Cell Exhaustion
Open Access
- 6 February 2026
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (6) , 995-1004
Abstract
Background: Little is known about the specific inflammatory networks and immune parameters that drive frailty outcomes in people with HIV (PWH). Methods: Plasma analytes and T-cell phenotypes from PWH without frailty (0 Fried score, n = 60) and with frailty (≥3 Fried score, n = 60) were measured by Luminex assay or flow cytometry. Multiple least-squares linear regression analysis was used to determine the association of each marker with frailty in unadjusted and adjusted models. Spearman correlations were used to determine the association of plasma analytes with T-cell phenotypes. Results: We found that 19 of 75 markers measured in plasma were significantly associated with frailty, most of which are downstream of NF-κB signaling and are senescence-associated secretory phenotype (SASP) components. In frail individuals, the proportions of CD4 and CD8 T cells with a naïve phenotype were significantly reduced, and the proportions of CD4 T cells expressing TIGIT and PD-1 were significantly elevated. Of the frailty-associated analytes, we found that only osteoprotegerin and TNF levels were significantly correlated with percent naïve, TIGIT+, and PD-1+ CD4 T cells among PWH with frailty. Osteoprotegerin levels were negatively correlated with CD4/CD8 T-cell ratio. Conclusions: We found a strong association of the SASP and NF-κB-related inflammation with frailty in PWH. Osteoprotegerin can inhibit osteoclast formation and prevent bone resorption. Low proportion of naïve CD4 T cells and increased TIGIT and PD-1 expression were associated with both osteoprotegerin levels and frailty, suggesting a link between inflammation, T-cell activation, bone health, and frailty in PWH.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (UM1 AI068634)
- National Institute of Allergy and Infectious Diseases (UM1 AI068636)
- National Institute of Allergy and Infectious Diseases (UM1 AI106701)
- AIDS Clinical Trials Group (AI068636)
- National Institute on Aging (K24 AG082527)
- U.S. Department of Veterans Affairs (BX006011)
This publication has 45 references indexed in Scilit:
- Alterations of receptors and insulin-like growth factor binding proteins in senescent cellsEuropean Journal of Cell Biology, 2024
- Hallmarks of aging and immunosenescence: Connecting the dotsCytokine & Growth Factor Reviews, 2021
- Probing the Interface of HIV and InflammagingCurrent HIV/AIDS Reports, 2021
- IL-6 can singlehandedly drive many features of frailty in miceGeroScience, 2021
- Aging with HIVCurrent HIV/AIDS Reports, 2019
- Receptor Activator of NF-κB Orchestrates Activation of Antiviral Memory CD8 T Cells in the Spleen Marginal ZoneCell Reports, 2017
- Cell Senescence Abrogates the Therapeutic Potential of Human Mesenchymal Stem Cells in the Lethal Endotoxemia ModelStem Cells, 2014
- The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune studyAGE, 2012
- Senescent cells as a source of inflammatory factors for tumor progressionCancer and Metastasis Reviews, 2010
- The immune risk phenotype is associated with IL-6 in the terminal decline stage: Findings from the Swedish NONA immune longitudinal study of very late life functioningMechanisms of Ageing and Development, 2006